Gingival crevicular fluid IL-6, tPA, PAI-2, albumin levels following initial periodontal treatment in chronic periodontitis patients with or without type 2 diabetes

KARDESLER, Levent; BUDUNELI, Nurcan; ÇETİNKALP, ŞEVKİ; Lappin, David; Kinane, Denis

doi:10.1007/s00011-010-0248-7

Gingival crevicular fluid IL-6, tPA, PAI-2, albumin levels following initial periodontal treatment in chronic periodontitis patients with or without type 2 diabetes

KARDESLER L., BUDUNELI N., ÇETİNKALP Ş. , Lappin D., Kinane D. F.

INFLAMMATION RESEARCH, vol.60, no.2, pp.143-151, 2011 (Journal Indexed in SCI)

Publication Type: Article / Article
Volume: 60 Issue: 2
Publication Date: 2011
Doi Number: 10.1007/s00011-010-0248-7
Title of Journal : INFLAMMATION RESEARCH
Page Numbers: pp.143-151
Keywords: Diabetes mellitus, ELISA, Gingival crevicular fluid, IL-6, Plasminogen activators, Periodontal disease, GLYCEMIC CONTROL, BONE LOSS, MELLITUS, THERAPY, INTERLEUKIN-1-BETA, DISEASE

Abstract

To evaluate initial periodontal treatment effects on gingival crevicular fluid (GCF) interleukin-6 (IL-6), tissue-type plasminogen activator (tPA), plasminogen activator inhibitor-2 (PAI-2), albumin levels in type 2 diabetic patients.